Open AccessPropafenone‐induced drug fever in the absence of agranulocytosis
Author(s) -
O' Rourke Daniel J.,
Palac Robert T.,
Holzberger Peter T.,
Gerling Barbara R.,
Greenberg Mark L.
Publication year - 1997
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.4960200715
Subject(s) - propafenone , medicine , discontinuation , drug , adverse effect , adverse drug reaction , intensive care medicine , pharmacology , atrial fibrillation
Propafenone is an antiarrhythmic drug used in the treatment of life‐threatening ventricular tachyarrhythmias. Adverse reactions necessitating discontinuation of the medication are common. Propafenone‐induced drug fever has not been definitively proven. We present a case report of drug fever secondary to propafenone, confirmed with rechallenge.